Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sarah A. Mossman"'
Autor:
Hailong Li, Sarah A. Mossman, Kim M. Cecil, Lu Lu, Xiaoqi Huang, Heidi K. Schroeder, Laura B. Ramsey, Jeffrey R. Strawn, Qiyong Gong, John A. Sweeney, Jeffrey A. Mills, Melissa P. DelBello, Sara T. Varney
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 60:1309-1318
Amygdala-ventrolateral prefrontal cortex (VLPFC) circuitry is disrupted in pediatric anxiety disorders, yet how selective serotonin reuptake inhibitors (SSRIs) affect this circuitry is unknown. We examined the impact of the SSRI escitalopram on funct
Autor:
Heidi K. Schroeder, William T. Baumel, Qiyong Gong, John A. Sweeney, Jeffrey R. Strawn, Jeffrey A. Mills, Hailong Li, Xiaoqi Huang, Sarah A. Mossman, Lu Lu, Kim M. Cecil
Publikováno v:
Neuropsychopharmacology
Anxiety disorders are the most common mental disorders in adolescents. However, only 50% of pediatric patients with anxiety disorders respond to the first-line pharmacologic treatments-selective serotonin reuptake inhibitors (SSRIs). Thus, identifyin
Autor:
Sarah A. Mossman, Heidi K. Schroeder, Eric T. Dobson, Kim M. Cecil, Paul E. Croarkin, Jeffrey R. Strawn, Sara T. Varney
Publikováno v:
J Affect Disord
Background The phenomenology and neurobiology of depressive symptoms in anxious youth is poorly understood. Methods Association networks of anxiety and depressive symptoms were developed in adolescents with generalized anxiety disorder (GAD; N=52, me
Autor:
Jeffrey A. Mills, Hailong Li, Sara T. Varney, Sarah A. Mossman, Lu Lu, Jeffrey R. Strawn, Amir Levine, Kim M. Cecil, Melissa P. DelBello, John A Sweeny, Xiaoqi Huang, Heidi K. Schroeder, Qiyong Gong
Publikováno v:
J Child Adolesc Psychopharmacol
Objectives: Placebo response is one of the most significant barriers to detecting treatment effects in pediatric (and adult) clinical trials focusing on affective and anxiety disorders. We sought to identify neurofunctional predictors of placebo resp
Publikováno v:
J Child Adolesc Psychopharmacol
OBJECTIVE: To identify predictors of medication-placebo differences in double-blind placebo-controlled antidepressant trials in children and adolescents with anxiety and depression. METHODS: Clinical trials in patients
Autor:
Heidi K. Schroeder, Sarah A. Mossman, Cole Brokamp, Jeffrey R. Strawn, Sara T. Varney, Amir Levine
Publikováno v:
ISEE Conference Abstracts. 2020
Background: Short-term ambient fine particulate matter has been associated with exacerbations of psychiatric disorders in children and adolescents as measured by psychiatric emergency department ut...
Autor:
Sara T. Varney, Jeffrey A. Mills, Laura B. Ramsey, Heidi K. Schroeder, Sarah A. Mossman, Kim M. Cecil, Melissa P. DelBello, Zeruesenay Desta, Ethan A. Poweleit, Jeffrey R. Strawn
Publikováno v:
J Clin Psychiatry
BACKGROUND Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat pediatric anxiety disorders, including generalized anxiety disorder (GAD); however, their efficacy and tolerability are difficult to predict. This study evaluated t
Autor:
Sara T. Varney, Brooks R. Keeshin, Sarah A. Mossman, Jeffrey R. Strawn, Gary J. Cornwall, Jeffrey A. Mills, Paul E. Croarkin
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 28:2-9
An increasing number of abandoned clinical trials have forestalled efforts to advance the evidence base for the treatment of mood and anxiety disorders in children and adolescents. With this in mind, we sought to present and validate a Bayesian appro
Autor:
Jeffrey R. Strawn, Sarah A. Mossman, Jeffrey A. Mills, Sara T. Varney, Katherine M.J. McMurray, Renu Sah, Lauren L. Vollmer, Heidi K. Schroeder
Publikováno v:
Brain, Behavior, and Immunity. 67:36-41
Background While disruption of acid-base homeostasis has been pathoetiologically implicated in panic disorder (PD), the mechanism by which pH imbalance is translated to panic pathophysiology is poorly understood. Recently, in a translational rodent m
Autor:
Sarah A. Mossman, Jeffrey R. Strawn, Marissa J. Luft, Emily Harris, Anne K. Tulisiak, Jillian A. Klein, Heidi K. Schroeder, Brooks R. Keeshin, Sara T. Varney, Sian Cotton
Publikováno v:
Current Problems in Pediatric and Adolescent Health Care. 47:15-24
Among pediatricians, perceived knowledge of efficacy, tolerability, dosing, and side effects of antidepressants represent significant sources of variability in the use of these medications in youth with depressive and anxiety disorders. Importantly,